These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 6647214)

  • 1. Reduction of infarct size: a misleading concept?
    Poole-Wilson PA
    Postgrad Med J; 1983; 59 Suppl 3():95-6. PubMed ID: 6647214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocardial and epicardial infarct size after preconditioning by a partial coronary artery occlusion without intervening reperfusion. Importance of the degree and duration of flow reduction.
    Koning MM; Gho BC; van Klaarwater E; Duncker DJ; Verdouw PD
    Cardiovasc Res; 1995 Dec; 30(6):1017-27. PubMed ID: 8746219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic estimation of infarct size during reperfusion.
    Roberts R; Ishikawa Y
    Circulation; 1983 Aug; 68(2 Pt 2):I83-9. PubMed ID: 6861332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction.
    Heusch G; Skyschally A; Gres P; van Caster P; Schilawa D; Schulz R
    Eur Heart J; 2008 Sep; 29(18):2265-75. PubMed ID: 18621770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of lidocaine and pyromecaine on the size of an experimental myocardial infarct].
    Goldshteĭne GKh; Tsorin IB; Chichkanov GG
    Biull Eksp Biol Med; 1986 Feb; 101(2):177-9. PubMed ID: 3947734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of nitroglycerin in limiting the area of necrosis in myocardial infarction].
    Grodecki J
    Folia Med Cracov; 1989; 30(1-2):31-7. PubMed ID: 2518365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac endothelin release and infarct size, myocardial blood flow, and ventricular function in canine infarction and reperfusion.
    Kelly RF; Hursey TL; Schaer GL; Piotrowski MJ; Dee SV; Parrillo JE; Hollenberg SM
    J Investig Med; 1996 Dec; 44(9):575-82. PubMed ID: 9035612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs.
    Vander Heide RS; Reimer KA
    Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of parathyroid hormone on myocardial bloodflow and infarct size following coronary artery occlusion in the dog.
    Hebden RA; Nathan HJ
    Can J Cardiol; 1994 May; 10(4):477-83. PubMed ID: 8193993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraction band necrosis: its modification by the free radical scavenger N-2-mercaptopropionyl glycine.
    Widman SC; Liang CS; Schenk EA; Hood WB
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):694-701. PubMed ID: 7532745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
    Mizumura T; Nithipatikom K; Gross GJ
    Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term inhibition of myocardial infarction by postconditioning during reperfusion.
    Mykytenko J; Kerendi F; Reeves JG; Kin H; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Basic Res Cardiol; 2007 Jan; 102(1):90-100. PubMed ID: 17003965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial).
    Brodie BR; Webb J; Cox DA; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Dulas D; Rutherford B; Antoniucci D; Stuckey T; Krucoff M; Gibbons R; Lansky A; Na Y; Mehran R; Stone GW;
    Am J Cardiol; 2007 Jun; 99(12):1680-6. PubMed ID: 17560875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial infarct size limitation. Principles, problems and possibilities.
    Yellon DM; Downey JM; Hearse DJ
    G Ital Cardiol; 1984 Nov; 14(11):892-900. PubMed ID: 6526206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylprednisolone interventions in myocardial infarction: a controversial subject.
    LeGal YM; Morrissey LL
    Can J Cardiol; 1990 Nov; 6(9):405-10. PubMed ID: 2276078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proceedings: Influence of streptokinase on the size of experimental myocardial infarct in the dog].
    Wende W; Stühlen HW; Holzhüter H; Bleifeld W; Meyer J; Wenzel E
    Z Kardiol; 1974; 0(Suppl 1):35. PubMed ID: 4432580
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of the extent of the zone at risk on the effectiveness of drugs in reducing infarct size.
    Ribeiro LG; Cheung W; Maroko PR
    Circulation; 1982 Jul; 66(1):181-6. PubMed ID: 7083505
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of the enkefalin analog tageflar on the evolution of experimental myocardial infarct].
    Galankina IE; Rogatskiĭ GG; Riabinin VA; Pekelis BL
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):55-7. PubMed ID: 3801133
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of the geometry of myocardial infarct size reduction with hyaluronidase.
    Kloner RA; Maroko PR; Braunwald E
    Proc Soc Exp Biol Med; 1980 Oct; 165(1):141-6. PubMed ID: 7422672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.